Resolution for winding up (MVL)
Amryt Pharma (UK) Limited enters members' voluntary liquidation
In short: Amryt Pharma (UK) Limited (company no. 10463152) entered members' voluntary liquidation, a solvent and planned closure, according to a Resolution for winding up (MVL) notice published in The London Gazette on 20 July 2026. The office holders are James Hawksworth; Terence Guy Jackson, appointed 9 July 2026.
The members of AMRYT PHARMA (UK) LIMITED passed a special and ordinary resolution on 9 July 2026 to voluntarily wind up the company and appointed James Hawksworth and Terence Guy Jackson as joint liquidators.
Notice details
- Company
- AMRYT PHARMA (UK) LIMITED
- Company number
- 10463152
- Registered office
- C/O Corporation Service Company (UK) Limited, 5 Churchill Place, 10th Floor, London E14 5HU
- Principal trading address
- C/O Corporation Service Company (UK) Limited, 5 Churchill Place, 10th Floor, London E14 5HU
- Office holder(s)/Liquidator(s)
- James Hawksworth; Terence Guy Jackson
- Office holder number(s)
- 22450; 16450
- Date of appointment
- 9 July 2026
- Appointed by
- Members of the company (by written resolution)
What this notice means
A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Read more: What is Liquidation?.
All notices for Amryt Pharma (UK) Limited
3 Gazette notices on record for company no. 10463152, newest first. The full history, with last filed accounts, is on the Amryt Pharma (UK) Limited company record.
- Notices to creditors (MVL) 20 Jul 2026
- Appointment of liquidators (MVL) 20 Jul 2026
How does this notice affect you?
Choose what applies and we'll point you at the right next step.
A written-off invoice rarely stops at the company that failed. The supplier left short is often the next business in difficulty — and the earlier that's dealt with, the more options stay open. If AMRYT PHARMA (UK) LIMITED owed you money, it's worth checking where that leaves you.
Unpaid wages, holiday pay and statutory redundancy are claimed from the government's Redundancy Payments Service, not from K2. The insolvency practitioner named in this notice should send you a case reference — you'll need it to claim.
K2's founder has turned around UK businesses since 1990, and K2 has backed and restructured them since 2001, including buying trade and assets out of distress. These situations move in days rather than months, so if you're looking at AMRYT PHARMA (UK) LIMITED or something similar, start the conversation early.
A members' voluntary liquidation is a solvent, orderly closure — often part of retirement, a group restructure, or moving on to the next venture. K2's founder has advised UK company directors since 1990 on restructuring and what comes next. If that's on your horizon, talk to us.
Related guidance
Free, practical guides from K2 on what this kind of notice means for directors.
More liquidation notices
Frequently asked questions
Is Amryt Pharma (UK) Limited in financial difficulty?
No — this is a solvent process. A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress. The London Gazette published a Resolution for winding up (MVL) for Amryt Pharma (UK) Limited (company no. 10463152) on 20 July 2026.
What does a Resolution for winding up (MVL) mean?
A members' voluntary liquidation (MVL) is the solvent, orderly winding-up of a company that can pay its debts in full — usually part of a director's retirement, a group restructure, or closing a company that has served its purpose. It is a planned closure, not a sign of financial distress.
Who is dealing with the liquidation?
The office holders named in the notice: James Hawksworth; Terence Guy Jackson, appointed 9 July 2026. Creditors, employees and anyone holding goods or money belonging to the company should contact them directly, quoting the company number.
Source: The London Gazette and Companies House. Contains public sector information licensed under the Open Government Licence v3.0. © Crown copyright. This page is provided by K2 Partners for information only and is not legal or financial advice.